Pear Therapeutics, Inc.

OTCPK:PEAR.Q Voorraadrapport

Marktkapitalisatie: US$142.0

Pear Therapeutics Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Pear Therapeutics has a total shareholder equity of $30.6M and total debt of $27.4M, which brings its debt-to-equity ratio to 89.7%. Its total assets and total liabilities are $95.1M and $64.5M respectively.

Belangrijke informatie

89.7%

Verhouding schuld/eigen vermogen

US$27.45m

Schuld

Rente dekkingsration/a
ContantUS$59.27m
AandelenUS$30.59m
Totaal verplichtingenUS$64.54m
Totaal activaUS$95.13m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Slammed 82% Pear Therapeutics, Inc. (NASDAQ:PEAR) Screens Well Here But There Might Be A Catch

Apr 17
Slammed 82% Pear Therapeutics, Inc. (NASDAQ:PEAR) Screens Well Here But There Might Be A Catch

Pear Therapeutics Lays Off 9% Of Workforce, Guides For $15 Million Revenue

Aug 18

Pear Therapeutics providing Core Behavioral with opioid use disorder digital therapeutic

Aug 03

Pear Therapeutics Sees Growing Fulfillment Rates And Payor Traction

May 21

Pear Therapeutics Guiding For Being 1% Down The Potential Runway In Current Markets

Apr 04

Even With Low Penetration Assumptions For PDTs, Pear Therapeutics Is A Buy

Jan 10

Analyse van de financiële positie

Kortlopende schulden: PEAR.Q's short term assets ($73.0M) exceed its short term liabilities ($49.4M).

Langlopende schulden: PEAR.Q's short term assets ($73.0M) exceed its long term liabilities ($15.1M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: PEAR.Q has more cash than its total debt.

Schuld verminderen: Insufficient data to determine if PEAR.Q's debt to equity ratio has reduced over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: Insufficient data to determine if PEAR.Q has enough cash runway based on its current free cash flow.

Voorspelling contante baan: Insufficient data to determine if PEAR.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Ontdek gezonde bedrijven